The Effect of Topical Lidocaine on Pain Scores During Manual Vacuum Aspiration for Nonviable Pregnancies

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Women and Infants Hospital of Rhode Island
Information provided by (Responsible Party):
Amanda Tower, Bridgeport Hospital
ClinicalTrials.gov Identifier:
NCT01708330
First received: October 11, 2012
Last updated: July 20, 2015
Last verified: July 2015

October 11, 2012
July 20, 2015
October 2012
July 2015   (final data collection date for primary outcome measure)
Pain during intracervical block [ Time Frame: immediate ] [ Designated as safety issue: No ]
Pain on visual analogue scale
Pain during intracervical block [ Time Frame: 1 hour ] [ Designated as safety issue: No ]
Pain on visual analogue scale
Complete list of historical versions of study NCT01708330 on ClinicalTrials.gov Archive Site
  • Pain during tenaculum placement [ Time Frame: immediate ] [ Designated as safety issue: No ]
    Pain on visual analogue scale
  • Pain during cervical dilation [ Time Frame: immediate ] [ Designated as safety issue: No ]
    Pain on visual analogue scale
  • Pain during uterine aspiration [ Time Frame: immediate ] [ Designated as safety issue: No ]
    Pain on visual analogue scale
  • Pain during tenaculum placement [ Time Frame: 1 hour ] [ Designated as safety issue: No ]
    Pain on visual analogue scale
  • Pain during cervical dilation [ Time Frame: 1 hour ] [ Designated as safety issue: No ]
    Pain on visual analogue scale
  • Pain during aspiration [ Time Frame: 1 hour ] [ Designated as safety issue: No ]
    Pain on visual analogue scale
Complications [ Time Frame: 1 hour after procedure ] [ Designated as safety issue: Yes ]
Complications [ Time Frame: 1 hour ] [ Designated as safety issue: Yes ]
 
The Effect of Topical Lidocaine on Pain Scores During Manual Vacuum Aspiration for Nonviable Pregnancies
Not Provided

When a patient requires a manual vacuum aspiration (MVA), whether for an undesired pregnancy, missed abortion, or other nonviable pregnancy, she is undergoing an emotional experience. She is grieving the loss of her pregnancy, and is then faced with the anxiety of an invasive and often painful procedure. Minimizing the pain during this procedure must not be overlooked. There have been no randomized controlled trials evaluating pain control during MVA for nonviable pregnancy, and the data is mixed regarding analgesia for MVA for an elective abortion or other office procedures.

Women being treated at the Women & Infants Triage who have experienced a first trimester missed abortion, inevitable abortion, incomplete abortion or other nonviable pregnancy and are being treated with an outpatient manual vacuum aspiration will be asked to enroll in this study. Those who wish to participate will be randomly assigned to treatment with lidocaine gel or a placebo gel applied to the cervix during their procedure.

The hypothesis is that topical lidocaine will decrease pain during manual vacuum aspiration.

Not Provided
Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Treatment
Nonviable Pregnancy
  • Drug: Lidocaine
    2% Lidocaine gel
  • Drug: Placebo gel
    odorless, colorless gel will be used as a placebo
    Other Name: KY Jelly
  • Placebo Comparator: Placebo gel
    Placebo gel applied topically to the cervix
    Intervention: Drug: Placebo gel
  • Experimental: Lidocaine gel
    2% lidocaine gel applied topically to the cervix
    Intervention: Drug: Lidocaine
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
70
Not Provided
July 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient at the Women and Infants Triage/Women's Emergency Department
  • Vital signs are stable
  • Ages 18 and older
  • Have a missed abortion, inevitable abortion, incomplete abortion or other nonviable pregnancy
  • Estimated gestational age up to 10 weeks
  • Undergoing MVA at the Women and Infants Triage/Women's Emergency Department
  • Able to read English or Spanish
  • Able to give informed consent for involvement in the study

Exclusion Criteria:

  • Allergic to lidocaine, iodine or betadine
  • Known sensitivity to any component of the lidocaine or placebo gel.
  • In acute distress
  • Unable to give informed consent
  • Unable to read English or Spanish
Female
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01708330
12-0039
No
Amanda Tower, Bridgeport Hospital
Bridgeport Hospital
Women and Infants Hospital of Rhode Island
Not Provided
Bridgeport Hospital
July 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP